All In Biotech

Drug Trial Radar · NCT04534491

Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

An Oxytrol Transdermal System Actual Use Study (Consumer Trial of Oxytrol, Control)

Last checked: Nov 20, 2026Latest source record: Oct 20, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

855

Actual

Start

May 25, 2010

Primary completion

Jun 22, 2011

Study completion Jun 22, 2011

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Sep 1, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.

Conditions

  • Overactive Bladder

Interventions

  • Oxybutynin (Oxytrol, BAY839380)Drug

    Oxybutynin transdermal patch, 3.9 mg daily (Oxytrol Transdermal System)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Percentage of Participants Who Did Not Stop Use When They Either Developed a New Symptom Referred to Anywhere in the Labeling or When Their Condition Worsened Including Abdominal and/or Pelvic Pain.Time frame: Approximately 15 weeks from subjects' initial purchase of Oxytrol

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stevenson Family Pharmacy

    Saint Joseph, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.